← 1AI

1AIALGORAE PHARMACEUTICALS LIMITED

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
31 July 2026, 19:14Quarterly Activities Report/Appendix 4C Cashflow StatementQuarterly ReportsMS19004, 19009
22 July 2026, 03:19Initial Director's Interest Notice - TVDirector Interests—02008
22 July 2026, 03:16Final Director's Interest Notice - BDDirector Interests—02010
22 July 2026, 03:14Notification of cessation of securities - 1AIOther—06027
15 July 2026, 18:59Nasdaq Pharma Chairman Troy Valentine Joins Algorae BoardCompany Administration—12001
7 July 2026, 02:29Cleansing NoticeSecurities Administration—06018
7 July 2026, 02:26Application for quotation of securities - 1AIOther—06020
3 July 2026, 19:03Peter Mac Testing Validates AlgoraeOS v2Company UpdateMS11001
2 July 2026, 19:47Updated - NSW Health Public Hospital Supply ContractCompany UpdateMS11001, 12008
1 July 2026, 19:03Algorae Awarded NSW Health Public Hospital Supply ContractCompany UpdateMS11001
1 July 2026, 02:19Company Secretary Appointment/ResignationCompany Administration—12007
29 June 2026, 19:02Algorae Named Launch Partner for Sovereign AI InitiativeCompany Update—11001
25 June 2026, 04:27Change of AuditorOther—12018
20 June 2026, 03:18Cleansing NoticeSecurities Administration—06018
20 June 2026, 03:15Application for quotation of securities - 1AIOther—06020
20 June 2026, 03:12Application for quotation of securities - 1AIOther—06020
17 June 2026, 04:03Proposed issue of securities - 1AISecurities Administration—06013
26 May 2026, 03:23Notification regarding unquoted securities - 1AIOther—06021
26 May 2026, 03:19Application for quotation of securities - 1AIOther—06020
18 May 2026, 18:54Algorae Expands AI Drug Combination PipelineCompany UpdateMS11001
6 May 2026, 18:541AI Executes License & Supply Agreement with Torrent PharmaCompany UpdateMS11001
30 Apr 2026, 18:39Quarterly Activities Report /Appendix 4C Cash Flow StatementQuarterly ReportsMS19003, 19008
28 Apr 2026, 18:35Algorae and Zydus Enter Exclusive Commercial AgreementCompany UpdateMS11001
21 Apr 2026, 18:37Investor WebinarPresentations—14014
8 Apr 2026, 03:23Cleansing NoticeSecurities Administration—06018
8 Apr 2026, 03:17Notification regarding unquoted securities - 1AIOther—06021
8 Apr 2026, 03:13Application for quotation of securities - 1AIOther—06020
8 Apr 2026, 03:13Application for quotation of securities - 1AIOther—06020
3 Apr 2026, 04:14Proposed issue of securities - 1AISecurities Administration—06013
3 Apr 2026, 04:08Algorae Pharmaceuticals Ltd Raises $3.9mCapital RaisingMS06003, 06009
2 Apr 2026, 20:38TGA Accepts Initial Registration Dossier for EvaluationCompany UpdateMS11001
30 Mar 2026, 19:56Peter Mac Partners with Algorae on AI ValidationCompany UpdateMS11001
28 Mar 2026, 05:15Cleansing NoticeSecurities Administration—06018
28 Mar 2026, 05:10Application for quotation of securities - 1AIOther—06020
20 Mar 2026, 20:00Appointment of Mr Waleed Elsayed as Head of SalesCompany Administration—12008
14 Mar 2026, 05:37Cleansing NoticeSecurities Administration—06018
14 Mar 2026, 05:31Application for quotation of securities - 1AIOther—06020
14 Mar 2026, 05:29Notification regarding unquoted securities - 1AIOther—06021
14 Mar 2026, 05:23Notification regarding unquoted securities - 1AIOther—06021
13 Mar 2026, 05:41Initial Director's Interest NoticeDirector Interests—02008
13 Mar 2026, 05:34Final Director's Interest NoticeDirector Interests—02010
10 Mar 2026, 19:57Algorae appoints Mr David Gulland to its Board of DirectorsCompany Administration—12001, 12008
6 Mar 2026, 05:25Notification regarding unquoted securities - 1AIOther—06021
6 Mar 2026, 05:20Change of Director's Interest Notice - DHDirector Interests—02009
6 Mar 2026, 05:15Cleansing NoticeSecurities Administration—06018
6 Mar 2026, 05:11Application for quotation of securities - 1AIOther—06020
28 Feb 2026, 05:16Cleansing NoticeSecurities Administration—06018
28 Feb 2026, 05:13Application for quotation of securities - 1AIOther—06020
28 Feb 2026, 01:01Half Year Report and Appendix 4DFinancial ResultsMS03004, 03009, 03010, 03015, 03019
20 Feb 2026, 05:13Letter to Optionholders - Expiry of Listed OptionsLetters & Addresses—06009, 16001
1–50 of 92
1 / 2